Q1 2014

Source filing unavailable

Q1 2014 · —

Revenue

$202.47M

+51.7% vs Q1 2013

Net Income

$55.47M

+84.0% vs Q1 2013

EPS Diluted

$0.68

+88.9% vs Q1 2013

Operating Income$82,904,000+70.6%

Operating Cash Flow$90,482,000+76.2%

Free Cash Flowderived

Same quarter

Metric	Q1 2014	Q1 2013	Q1 2012	Q1 2011
Revenue	$202.47M	$133.44M	$110.45M	$91.86M
Net Income	$55.47M	$30.14M	$25.10M	$22.54M
EPS Diluted	$0.68	$0.36	$0.29	$0.24

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR